Bromodomain Factor 5 as a Target for Antileishmanial Drug Discovery.
Russell CN, Carter JL, Borgia JM, Bush J, Calderón F, Gabarró R, Conway SJ, Mottram JC, Wilkinson AJ, Jones NG.
Russell CN, et al. Among authors: jones ng.
ACS Infect Dis. 2023 Nov 10;9(11):2340-2357. doi: 10.1021/acsinfecdis.3c00431. Epub 2023 Oct 31.
ACS Infect Dis. 2023.
PMID: 37906637
Free PMC article.